#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

CS

Editorial

Czech version

Published in: Diab Obez 2024; 24(47): 3
Category: Editorial

Labels

Diabetology Obesitology

Early use of SGLT2-inhibitors i in the treatment of type 2 diabetes mellitus

Integration of glycemic compensation markers, including glycemic variability in patients with diabetes mellitus

Metformin in the treatment of type 2 diabetes mellitus and its current position

Inklisiran and its role in lipid-lowering therapy

Slovak Diabetes Society recommendations for diabetes education

Type 2 diabetes mellitus and obesity – dangerous companions

Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus

Current position of GLP-1 receptor agonists in type 2 diabetes mellitus treatment

Long-term sustainability of metabolic compensation in telemedicine use – results of 18 months follow-up

Diabetic distress from clinical diabetology view

6th National SDS Symposium: Where are we moving with technology in diabetology in Slovakia?

Pilot project for early detection of hyperglycemia, prediabetes and/or diabetes mellitus in insured persons of VšZP, a.s., and throughout Slovakia in specialist outpatient clinics of diabetologists in diabetes-naïve patients: report

Advanced Technologies & Treatments for Diabetes 2024, Florencia – sumár z kongresu

MUDr. Lívia Tomášová

MUDr. Adriana Philippiová

Diabetics from all over Slovakia on reconditioning stays

Article was published in

Diabetes and obesity

Issue 47

2024 Issue 47

Most read in this issue

Topics

Journals

#ADS_BOTTOM_SCRIPTS#